Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison'

Impact · against what's priced in

The article contains no material new catalysts for the individual holdings in ARKK, as the focus is on Cathie Wood's defense of fund performance and general portfolio weighting. While it confirms ARKK's high exposure to AI-driven healthcare, these thematic allocations are already reflected in the valuations of the underlying stocks.

TEM+0.00: Already priced in
The price assumes: the company's trajectory toward operating breakeven

Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison'

What matters in this story

Strength Seen in Genmab (GMAB): Can Its 10.7% Jump Turn into More Strength?

Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison'

What matters in this story

Strength Seen in Genmab (GMAB): Can Its 10.7% Jump Turn into More Strength?

How each ticker is affected

Connected tickers

Track these names every morning.

Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

Missed this Vanguard ETF's 37% rally? Here's what $10,000 could do next

Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison'

What matters in this story

Next reads from the same story arc

Strength Seen in Genmab (GMAB): Can Its 10.7% Jump Turn into More Strength?

Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison'

What matters in this story

Next reads from the same story arc

Strength Seen in Genmab (GMAB): Can Its 10.7% Jump Turn into More Strength?

How each ticker is affected

Connected tickers

Track these names every morning.

Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

Missed this Vanguard ETF's 37% rally? Here's what $10,000 could do next